CLINICAL_TRIALS
trial_result
· 2023-01-17
Clinical Trial Update: Mobilization of Endothelial Progenitor Cells and Aspirin [Phase 3]
Summary
A Phase 3 trial investigating mobilization of endothelial progenitor cells and aspirin in hypertrophic obstructive cardiomyopathy was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Hypertrophic Obstructive Cardiomyopathy | Phase 3 | Status: TERMINATED